Campaigners demand end to patents on life

By: Katie Mantell

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Campaigners demand end to patents on life</h1>
<h4>By: Katie Mantell</h4>
</div>
<br />
<br />

<div id="article-body">
<p><STRONG>Anti-biotechnology activists and non-governmental organisations from more than 50 nations have announced their support for a proposal to establish an international treaty that aims to ban the patenting of plant and animal life.</STRONG><BR><BR>The move is intended as a protest against the growing number of patents on human, animal and plant genes and genetically engineered organisms that have been granted to companies and institutions — giving them exclusive rights to what the campaigners say is a ‘shared legacy’.<BR><BR>“The gene pool should not be allowed to be claimed as commercially negotiable genetic information or intellectual property by governments, commercial enterprises, other institutions or individuals,” says Jeremy Rifkin, president of the US-based Foundation on Economic Trends, one of the leading organisations behind the treaty.<BR><BR>But industry representatives argue that gene patenting is vital to allow companies to recoup their investment in the research needed to produce new products. “The patent system has been working to date and has allowed for the development of medicines and new technologies,” says a spokesperson from the Association of the British Pharmaceutical Industry.<BR><BR>The Treaty to Share the Genetic Commons is supported by more than 250 non-governmental organisations from both North and South. They plan to encourage governments to adopt the treaty at the Rio+10 conference in South Africa later this year. <BR><BR>The activists argue that the current patenting system, which allows companies from the developed world to patent genes originating in organisms from the biodiversity-rich developing countries, conflicts with the rights of nation states and indigenous peoples. “It is a classic case of colonialism, but now in the form of biocolonialism,” says Rifkin.<BR><BR>They also argue that it is wrong to talk of a scientist ‘inventing’ a life-form, seed, cell line, protein or DNA sequence.<BR><BR>But Rifkin acknowledges that creating a legally-binding treaty prohibiting all patents on life will not be easy. “I’m looking at a time plan of 20 years,” he says.<BR><BR>© SciDev.Net 2002</p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/news/campaigners-demand-end-to-patents-on-life/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/news/campaigners-demand-end-to-patents-on-life/",null,true])
</script>
</div>

Anti-biotechnology activists and non-governmental organisations from more than 50 nations have announced their support for a proposal to establish an international treaty that aims to ban the patenting of plant and animal life.

The move is intended as a protest against the growing number of patents on human, animal and plant genes and genetically engineered organisms that have been granted to companies and institutions — giving them exclusive rights to what the campaigners say is a ‘shared legacy’.

“The gene pool should not be allowed to be claimed as commercially negotiable genetic information or intellectual property by governments, commercial enterprises, other institutions or individuals,” says Jeremy Rifkin, president of the US-based Foundation on Economic Trends, one of the leading organisations behind the treaty.

But industry representatives argue that gene patenting is vital to allow companies to recoup their investment in the research needed to produce new products. “The patent system has been working to date and has allowed for the development of medicines and new technologies,” says a spokesperson from the Association of the British Pharmaceutical Industry.

The Treaty to Share the Genetic Commons is supported by more than 250 non-governmental organisations from both North and South. They plan to encourage governments to adopt the treaty at the Rio+10 conference in South Africa later this year.

The activists argue that the current patenting system, which allows companies from the developed world to patent genes originating in organisms from the biodiversity-rich developing countries, conflicts with the rights of nation states and indigenous peoples. “It is a classic case of colonialism, but now in the form of biocolonialism,” says Rifkin.

They also argue that it is wrong to talk of a scientist ‘inventing’ a life-form, seed, cell line, protein or DNA sequence.

But Rifkin acknowledges that creating a legally-binding treaty prohibiting all patents on life will not be easy. “I’m looking at a time plan of 20 years,” he says.

© SciDev.Net 2002